search
Back to results

Rotational Stability Analysis of a Toric Monofocal IOL (PHY2013)

Primary Purpose

Cataract, Lens Opacities, Astigmatism

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
IOL implantation experimental
Sponsored by
Beaver-Visitec International, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cataract focused on measuring Intraocular Lens, Monofocal, Toric Lens

Eligibility Criteria

50 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Cataracteous Eyes with no comorbidity
  • Regular corneal astigmatism >1 dioptre and <3D determined by an automatic keratometer (regularity determined by the topography of the keratometry).
  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
  • Signed informed consent •>50 years old

Exclusion Criteria:

  • Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…)
  • Any ocular comorbidity
  • History of ocular trauma or prior ocular surgery including refractive procedures
  • Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, Marfan's syndrome)
  • Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)

Sites / Locations

  • Ruhr-Universitat Bochum, Bochum, Germany

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Ankoris IOL Implantation experimental

Arm Description

Monolateral implantation of toric intraocular lenses Ankoris

Outcomes

Primary Outcome Measures

Rotational stability - Photograph of IOL with dilated pupil to asses IOL rotation
Rotational stability of the ANKORIS is evaluated on the basis of slit-lamp photographies to capture the iris and the marks onto the lens. Descriptive statistics will be used to determine the IOL stability.

Secondary Outcome Measures

Residual astigmatism after Ankoris implantation with respect to the targeted astigmatism correction.
Visual performance is determined in terms of monocular uncorrected distance visual acuity (UDVA), distance corrected visual acuity (DCVA) and postoperative refraction. Efficiency will be assessed using Alpins method.

Full Information

First Posted
June 18, 2021
Last Updated
June 18, 2021
Sponsor
Beaver-Visitec International, Inc.
Collaborators
targomedGmbH
search

1. Study Identification

Unique Protocol Identification Number
NCT04933487
Brief Title
Rotational Stability Analysis of a Toric Monofocal IOL
Acronym
PHY2013
Official Title
Prospective Evaluation of the Rotational Stability of the Ankoris Intraocular Lens
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
August 26, 2014 (Actual)
Primary Completion Date
January 1, 2016 (Actual)
Study Completion Date
March 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Beaver-Visitec International, Inc.
Collaborators
targomedGmbH

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a single-center, prospective PMCF study whereby patients undergoing routine cataract surgery will have monolateral implantation of hydrophilic monofocal toric intraocular lens Ankoris.
Detailed Description
This is a single-center, prospective, nonrandomized PMCF study whereby patients undergoing routine cataract surgery will have monolateral implantation of hydrophilic monofocal toric intraocular lens (Ankoris). The device under investigation is manufactured by the sponsor of this study. The refractive power of the lens has a spherical and a cylindrical component. The IOLs will be implanted in the course of routine cataract surgery and will benefit to patients suffering from cataract development and showing pre-existing corneal astigmatism. The primary objective of this study is to determine the rotational stability of the Ankoris intraocular lens. The secondary objective is to measure the residual astigmatism after Ankoris implantation with respect to the targeted astigmatism correction. In total approx. 20 eyes of 20 patients will be recruited for this clinical study. Follow-ups will be performed 1 day, 1 month, and 3 months after cataract surgery. Subjects would have the option for unscheduled visits if required medically.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract, Lens Opacities, Astigmatism
Keywords
Intraocular Lens, Monofocal, Toric Lens

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
23 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Ankoris IOL Implantation experimental
Arm Type
Experimental
Arm Description
Monolateral implantation of toric intraocular lenses Ankoris
Intervention Type
Device
Intervention Name(s)
IOL implantation experimental
Intervention Description
Monolateral implantation of toric intraocular lenses Ankoris. (Manufactured by PhysIOL sa/nv, Liège, Belgium).
Primary Outcome Measure Information:
Title
Rotational stability - Photograph of IOL with dilated pupil to asses IOL rotation
Description
Rotational stability of the ANKORIS is evaluated on the basis of slit-lamp photographies to capture the iris and the marks onto the lens. Descriptive statistics will be used to determine the IOL stability.
Time Frame
3 months postoperative
Secondary Outcome Measure Information:
Title
Residual astigmatism after Ankoris implantation with respect to the targeted astigmatism correction.
Description
Visual performance is determined in terms of monocular uncorrected distance visual acuity (UDVA), distance corrected visual acuity (DCVA) and postoperative refraction. Efficiency will be assessed using Alpins method.
Time Frame
Follow-ups will be performed 1 day, 1 month, and 3 months after cataract surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Cataracteous Eyes with no comorbidity Regular corneal astigmatism >1 dioptre and <3D determined by an automatic keratometer (regularity determined by the topography of the keratometry). Availability, willingness and sufficient cognitive awareness to comply with examination procedures Signed informed consent •>50 years old Exclusion Criteria: Acute or chronic disease or illness that would increase risk or confound study results (e.g. diabetes mellitus (with retinopathy), immunocompromised, glaucoma etc…) Any ocular comorbidity History of ocular trauma or prior ocular surgery including refractive procedures Capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome, Marfan's syndrome) Pupil abnormalitis (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic/scotopic conditions)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Burkhard Dick, MD
Organizational Affiliation
Ruhr-Universitat Bochum, Bochum, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ruhr-Universitat Bochum, Bochum, Germany
City
Bochum
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Rotational Stability Analysis of a Toric Monofocal IOL

We'll reach out to this number within 24 hrs